Your browser doesn't support javascript.
loading
Prehospital Transdermal Glyceryl Trinitrate for Ultra-Acute Intracerebral Hemorrhage: Data From the RIGHT-2 Trial.
Bath, Philip M; Woodhouse, Lisa J; Krishnan, Kailash; Appleton, Jason P; Anderson, Craig S; Berge, Eivind; Cala, Lesley; Dixon, Mark; England, Timothy J; Godolphin, Peter J; Hepburn, Trish; Mair, Grant; Montgomery, Alan A; Phillips, Stephen J; Potter, John; Price, Chris I; Randall, Marc; Robinson, Thompson G; Roffe, Christine; Rothwell, Peter M; Sandset, Else C; Sanossian, Nerses; Saver, Jeffrey L; Siriwardena, A Niroshan; Venables, Graham; Wardlaw, Joanna M; Sprigg, Nikola.
Affiliation
  • Bath PM; From the Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, United Kingdom (P.M.B., L.J.W., J.P.A., M.D., N.S.).
  • Woodhouse LJ; Stroke, Nottingham University Hospitals National Health Service (NHS) Trust, City Hospital Campus, United Kingdom (P.M.B., K.K., N.S.).
  • Krishnan K; From the Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, United Kingdom (P.M.B., L.J.W., J.P.A., M.D., N.S.).
  • Appleton JP; Stroke, Nottingham University Hospitals National Health Service (NHS) Trust, City Hospital Campus, United Kingdom (P.M.B., K.K., N.S.).
  • Anderson CS; From the Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, United Kingdom (P.M.B., L.J.W., J.P.A., M.D., N.S.).
  • Berge E; The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, Australia (C.S.A.).
  • Cala L; The George Institute China at Peking University Health Science Center, Beijing, China (C.S.A.).
  • Dixon M; Neurology Department, Royal Prince Alfred Hospital, Sydney Health Partners, NSW, Australia (C.S.A.).
  • England TJ; Department of Internal Medicine (E.B., A.N.S), Oslo University Hospital, Norway.
  • Godolphin PJ; Department of Neurology (E.C.S.), Oslo University Hospital, Norway.
  • Hepburn T; Faculty of Health and Medical Sciences, University of Western Australia (L.C.).
  • Mair G; From the Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, United Kingdom (P.M.B., L.J.W., J.P.A., M.D., N.S.).
  • Montgomery AA; East Midlands Ambulance Service NHS Trust, Nottingham, United Kingdom (M.D.).
  • Phillips SJ; Vascular Medicine, Division of Medical Sciences, GEM, Royal Derby Hospital Centre (T.J.E.), University of Nottingham, United Kingdom.
  • Potter J; Nottingham Clinical Trials Unit, Queen's Medical Centre (P.J.G., T.H., A.A.M.), University of Nottingham, United Kingdom.
  • Price CI; Nottingham Clinical Trials Unit, Queen's Medical Centre (P.J.G., T.H., A.A.M.), University of Nottingham, United Kingdom.
  • Randall M; Centre for Clinical Brain Sciences, Edinburgh Imaging and UK Dementia Research Institute at the University of Edinburgh, Chancellor's Building (G.M., J.M.W.).
  • Robinson TG; Nottingham Clinical Trials Unit, Queen's Medical Centre (P.J.G., T.H., A.A.M.), University of Nottingham, United Kingdom.
  • Roffe C; Department of Medicine, Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, Canada (S.J.P.).
  • Rothwell PM; Bob Champion Research and Education Building, University of East Anglia, Norwich, United Kingdom (J.P.).
  • Sandset EC; Institute of Neuroscience, Newcastle University, United Kingdom (C.I.P.).
  • Sanossian N; Department of Neurology, Leeds Teaching Hospitals NHS Trust, United Kingdom (M.R.).
  • Saver JL; Department of Cardiovascular Sciences and NIHR Leicester Biomedical Research Centre, University of Leicester, United Kingdom (T.G.R.).
  • Siriwardena AN; Stroke Research in Stoke, Institute for Science and Technology in Medicine, Keele University, Stoke-on-Trent, United Kingdom (C.R.).
  • Venables G; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, United Kingdom (P.M.R.).
  • Wardlaw JM; Research and Development, The Norwegian Air Ambulance Foundation, Oslo, Norway (E.C.S.).
  • Sprigg N; Department of Neurology, University of Southern California Keck School of Medicine, Los Angeles (N.S.).
Stroke ; 50(11): 3064-3071, 2019 11.
Article in En | MEDLINE | ID: mdl-31587658

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Blood Pressure / Cerebral Hemorrhage / Hospital Mortality / Nitroglycerin / Stroke / Emergency Medical Services Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Stroke Year: 2019 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Blood Pressure / Cerebral Hemorrhage / Hospital Mortality / Nitroglycerin / Stroke / Emergency Medical Services Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Stroke Year: 2019 Document type: Article